using pt141 Double-blind, placebo-controlled evaluation of the
Double blind, placebo controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT 141, a melanocortin receptor agonist, in healthy males and patients with mild to moderate erectile dysfunction PT 141 (Bremelanotide) Peptide Libido & Arousal Luxara Labs PT 141 Protocol $189 mo PlexusDx PT 141 Bremelanotide Nasal Spray Town & Country Compounding
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



